President Trump has long positioned himself as a champion of law and order, American innovation, and supply chain sovereignty.
This is his chance to draw a hard line: crack down on compounders, strengthen patent enforcement, and block unregulated, foreign ingredients from entering our borders.
A black market in weight-loss drugs is flourishing in plain sight.
Rogue pharmacies and telehealth firms are flooding the United States with unauthorized knock-offs of semaglutide, tirzepatide, and other glucagon-like peptide-1 drugs.
Better known by brand names like Ozempic, Wegovy, Mounjaro, and Zepbound, the knock-off versions of these drugs are being manufactured with foreign ingredients, often sourced from China, and are not subject to approval by the U.S. Food and Drug Administration.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
What’s The GLP-1 Black Market, How Big a Threat Is It?
Sally C. Pipes
President Trump has long positioned himself as a champion of law and order, American innovation, and supply chain sovereignty.
This is his chance to draw a hard line: crack down on compounders, strengthen patent enforcement, and block unregulated, foreign ingredients from entering our borders.
A black market in weight-loss drugs is flourishing in plain sight.
Rogue pharmacies and telehealth firms are flooding the United States with unauthorized knock-offs of semaglutide, tirzepatide, and other glucagon-like peptide-1 drugs.
Better known by brand names like Ozempic, Wegovy, Mounjaro, and Zepbound, the knock-off versions of these drugs are being manufactured with foreign ingredients, often sourced from China, and are not subject to approval by the U.S. Food and Drug Administration.
Read the op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.